In the present study, the effect of dual MEK/Aurora kinase inhibitor BI-847325 on the key biological processes involved in cancer progression including cell cycle, apoptosis, proliferation, differentiation, invasion, angiogenesis, and drug resistance was evaluated using a 3D in vitro ATC model at the molecular and/or cellular levels. This evidence concerns the gene MAP2K7 and cancer.